Effect of pcsk9 antibodies on neurocognitive outcomes and improved survival in patients at higher risk: a meta-analysis of randomised controlled trials
Proceedings article published in 2016 by
M. Kolodziejczak,
D. Dimitroulis,
M. Brockmeyer,
G. Wolff,
Ep Navarese 
